A new investment of C$4.6 million from the Ontario government will expand the McMaster Nuclear Reactor's operations to 24/7 to boost medical radioisotope production. This brings Ontario's total investment in the facility to C$26.9 million, increasing its research capacity by 300% and enabling enough radioisotopes for 84,000 cancer treatments annually. The reactor, operational since 1959, produces about 60% of the world's iodine-125, widely used in cancer treatment. Ontario officials emphasized the importance of this investment in supporting local health initiatives and maintaining the province’s leadership in nuclear medicine. Other notable developments include Canada launching a long-term Nuclear Energy Strategy and ongoing collaborations for recovering and repurposing nuclear materials.
Sun, 09 Aug 2026 23:35:49 GMT | American Nuclear Society -- ANS